INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

May 1, 2024

Period of Report

April 29, 2024

Accession Number

0001062993-24-009173